Nobilis Health Corp.
NHC.TO
TSX
| 06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | |
|---|---|---|---|---|---|
| Revenue | -15.08% | -5.53% | -18.60% | -9.59% | 31.42% |
| Total Other Revenue | 82.45% | -59.99% | 29.87% | 21.30% | -35.08% |
| Total Revenue | -13.47% | -7.14% | -17.50% | -8.53% | 29.24% |
| Cost of Revenue | -4.67% | -6.85% | -3.89% | -8.93% | 13.03% |
| Gross Profit | -18.21% | -7.34% | -23.62% | -8.26% | 40.06% |
| SG&A Expenses | -20.61% | -13.78% | -29.73% | -16.15% | 19.38% |
| Depreciation & Amortization | 85.47% | 95.17% | 64.97% | 38.31% | 36.51% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.36% | -7.36% | -17.11% | -11.72% | 17.41% |
| Operating Income | -44.08% | 12.28% | -18.99% | 216.53% | 13,327.27% |
| Income Before Tax | -59.39% | -2.34% | 8.74% | 96.12% | 152.01% |
| Income Tax Expenses | -77.99% | 54.61% | 97.86% | -114.49% | 779.46% |
| Earnings from Continuing Operations | -46.54% | -42.38% | -32.19% | 100.04% | 29.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 48.80% | -270.31% | -32.68% | 304.23% | -172.89% |
| Net Income | -44.16% | -60.63% | -61.61% | 136.75% | -67.02% |
| EBIT | -44.08% | 12.28% | -18.99% | 216.53% | 13,327.27% |
| EBITDA | -8.39% | 376.61% | -11.18% | 340.00% | 382.62% |
| EPS Basic | -44.61% | -60.06% | -62.06% | 136.21% | -67.41% |
| Normalized Basic EPS | -69.60% | -22.09% | -19.56% | 159.52% | -52.31% |
| EPS Diluted | -43.50% | -62.34% | -61.20% | 125.00% | -66.67% |
| Normalized Diluted EPS | -70.93% | -22.09% | -18.99% | 159.05% | -51.80% |
| Average Basic Shares Outstanding | 0.49% | 0.49% | 1.20% | 1.34% | 1.37% |
| Average Diluted Shares Outstanding | 5.17% | 0.49% | 0.52% | 1.77% | 0.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
